Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Comparing two nerve-block combinations to reduce pain after total knee replacement

Official title: Comparison of Distal IPACK and Popliteal Plexus Block Combined With Femoral Triangle Block After Total Knee Arthroplasty

Run by Karaman Training and Research Hospital · NCT07130552 · Data updated 2026-11-12

This test compares whether adding a distal IPACK block or a popliteal plexus block to a femoral triangle block reduces pain after total knee replacement.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment120 (estimated)
SponsorKaraman Training and Research Hospital
Academic / other
Locations1 site (Karaman)
StatusRecruiting
StartedDecember 29, 2025
Main results expectedDecember 25, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 22, 2026
Trial IDNCT07130552 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for total knee arthroplasty under spinal anesthesia with ASA I–III who can give informed consent are suitable candidates.

Probably not a fit

Patients with GFR <50 ml/min, daily long‑term opioid use, lower‑extremity neurological disorders, allergy to local anesthetics, or other contraindications to peripheral nerve blocks may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial randomizes patients having total knee arthroplasty under spinal anesthesia to receive a femoral triangle block combined with either a popliteal plexus block (PPB) or a distal IPACK block as part of multimodal analgesia. Postoperative pain scores at rest and with movement, opioid consumption, and early functional outcomes will be recorded to compare analgesic effectiveness. The IPACK involves ultrasound‑guided infiltration between the popliteal artery and the posterior knee capsule and has been linked to lower pain and opioid needs, while PPB is a newer technique targeting posterior knee innervation. The goal is to identify which block combination gives better posterior‑knee pain relief with minimal motor impairment.

Why it matters

Potential benefit: If successful, patients could have less postoperative pain, reduced opioid use, and faster functional recovery after knee replacement.

How similar studies have gone: IPACK has been associated with reduced postoperative pain and opioid consumption in prior work, whereas the popliteal plexus block is promising but lacks head‑to‑head comparison with distal IPACK.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing total knee arthroplasty under spinal anesthesia
* American Society of Anesthesiologists (ASA) status I-III
* Patients who give informed consent

Exclusion Criteria:

* Patients unable to cooperate
* Kidney disease with GFR \< 50 ml/min
* Daily opioid consumption \> 1 month
* Allergy to local anesthetics
* Neurological problems of the lower extremity
* Contraindications to peripheral nerve blocks

Where it's running

  • Karaman Training and Research Hospital, Karaman, Karaman 70200
    Karaman, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.